CN1259360A - Medicine for treating pulmonary hart diseases - Google Patents
Medicine for treating pulmonary hart diseases Download PDFInfo
- Publication number
- CN1259360A CN1259360A CN98123782A CN98123782A CN1259360A CN 1259360 A CN1259360 A CN 1259360A CN 98123782 A CN98123782 A CN 98123782A CN 98123782 A CN98123782 A CN 98123782A CN 1259360 A CN1259360 A CN 1259360A
- Authority
- CN
- China
- Prior art keywords
- medicine
- radix
- herba
- root
- diseases
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Abstract
A traditional Chinese prescription medicine is made from pilose asiabell root, astragalus root, poria, schisandra fruit, ephedra, ramulus cinnamomi, perilla seed, asarum herb, Chinese angelica root, herba lycopi, pinellia tuber, cortex acanthopanacis radicis, licorice, lumbricus etc through conventional prepn method. Said medicine possesses the functions of benefiting vital energy and promoting blood circulation, strengthening heart and benefiting lung, stopping cough and relieving phlegm, calming asthma etc.
Description
The present invention relates to a kind of medicine for the treatment of pulmonary heart disease, specifically is the herbal mixture lung heart health of feedstock production with the Chinese herbal medicine.
Chronic pulmonary heart disease (Chronjccorpdlmondle) is called for short pulmonary heart disease, is a kind of commonly encountered diseases, frequently-occurring disease and difficult and complicated illness.In recent years, this sick sickness rate is in rising trend, and is particularly very big to healthy elder harm.At present, to the treatment of pulmonary heart disease, modern medicine is from heart tonifying, diuresis, infection or symptomatic treatment, can only mitigation symptoms, be difficult to cure, and also there is not the reliable medicine of an ideal Therapeutic Method of cover and the disease of specially effecting a permanent cure.Motherland's medical science from differential diagnosis of diseases with distinguish disease combining, use differentiation of symptoms and signs for classification of syndrome with in many ways, compound recipe carries out clinical observation research, obtains certain curative effect, but also do not succeed in developing reliable, the stable pure Chinese medicinal preparation of a kind of curative effect, meet clinical needs.
The heart failure, disturbance of blood circulation, water liquid Metabolic disorder, the pulmonary infection that the objective of the invention is to from pulmonary heart disease are started with, select for use have heart tonifying, the Chinese medicine of blood circulation promoting and blood stasis dispelling, relieving cough and asthma, inducing diuresis to remove edema forms effective preparation, thereby reaches the curative effect for the treatment of both the principal and secondary aspects of a disease.
Solution of the present invention, be based on understanding and the Therapeutic Principle of motherland's medical science to pulmonary heart disease, use the experience of tcm treatment according to syndrome differentiation, screening is sent as an envoy to its Chinese herbal medicine of effect with benefiting QI for activating blood circulation, heart tonifying lung benefiting, relieving cough and resolving phlegm, the diuretic of relievining asthma by the theory of Chinese medical science prescription, skim the cream off milk, according to a conventional method preparation.
Among the present invention, the percentage by weight of each raw material of Chinese medicine is:
Radix Codonopsis 10-25% Radix Astragali 10-25% Poria 5-15% Fructus Schisandrae Chinensis 5-15%
Herba Ephedrae 4-8% Ramulus Cinnamomi 4-8% Fructus Perillae 4-8% Herba Asari 2-5%
Rhizoma Pinelliae 4-8% Radix Angelicae Sinensis 4-8% Herba Lycopi 4-8% periploca sepium 2-5%
Radix Glycyrrhizae 2-5% Pheretima 4-8%.
Clinical drug of the present invention uses the result to show that following advantage is arranged:
1, compatibility uniqueness of the present invention has the effect of benefiting QI for activating blood circulation, the sharp lung of heart tonifying, relieving cough and asthma, inducing diuresis to remove edema; Through clinical 180 routine observation of curative effect, wherein to cure 58 examples and account for 32%, 108 examples that are clearly better account for 60%, and invalid 14 examples account for 8%, and total effective rate is 92%.
2, intoxicating phenomenon does not take place in the present invention after mice lavage surpasses safe dose, thereby the present invention has no side effect, and is safe and effective.
3, preparation of the present invention can be suitable for preventing and treating chronic tracheitis, pulmonary heart disease and disease such as nervously breathing hard of causing, cough and asthma, abundant expectoration, cyanosis, edema.
Embodiments of the invention are:
Embodiment one:
A kind of medicine for the treatment of pulmonary heart disease is by the raw material of Chinese medicine of the following weight percent medicament made of formulation method routinely: Radix Codonopsis 19%, the Radix Astragali 19%, Poria 10%, Fructus Schisandrae Chinensis 10%, Herba Ephedrae 5%, Ramulus Cinnamomi 5%, Fructus Perillae 5%, Herba Asari 2%, the Rhizoma Pinelliae 5%, Radix Angelicae Sinensis 5%, Herba Lycopi 6%, periploca sepium 2%, Radix Glycyrrhizae 2%, Pheretima 5%.
Embodiment two:
A kind of medicine for the treatment of pulmonary heart disease is by the raw material of Chinese medicine of the following weight percent medicament made of formulation method routinely: Radix Codonopsis 10%, the Radix Astragali 18%, Poria 6%, Fructus Schisandrae Chinensis 12%, Herba Ephedrae 7%, Ramulus Cinnamomi 7%, Fructus Perillae 7%, Herba Asari 4%, the Rhizoma Pinelliae 7%, Radix Angelicae Sinensis 7%, Herba Lycopi 7%, periploca sepium 4%, Radix Glycyrrhizae 4%, Pheretima 7%.
Claims (1)
1, a kind of medicine for the treatment of pulmonary heart disease is characterized in that it is by the raw material of Chinese medicine of the following weight percent medicament made of formulation method routinely:
Radix Codonopsis 10-25% Radix Astragali 10-25% Poria 5-15% Fructus Schisandrae Chinensis 5-15%
Herba Ephedrae 4-8% Ramulus Cinnamomi 4-8% Fructus Perillae 4-8% Herba Asari 2-5%
Rhizoma Pinelliae 4-8% Radix Angelicae Sinensis 4-8% Herba Lycopi 4-8% periploca sepium 2-5%
Radix Glycyrrhizae 2-5% Pheretima 4-8%.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN98123782A CN1123354C (en) | 1998-10-29 | 1998-10-29 | Medicine for treating pulmonary hart diseases |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN98123782A CN1123354C (en) | 1998-10-29 | 1998-10-29 | Medicine for treating pulmonary hart diseases |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1259360A true CN1259360A (en) | 2000-07-12 |
CN1123354C CN1123354C (en) | 2003-10-08 |
Family
ID=5228352
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN98123782A Expired - Fee Related CN1123354C (en) | 1998-10-29 | 1998-10-29 | Medicine for treating pulmonary hart diseases |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1123354C (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100490787C (en) * | 2003-12-26 | 2009-05-27 | 王保安 | Capsule for treating heart palpitation |
CN104524535A (en) * | 2015-01-15 | 2015-04-22 | 范丰双 | Traditional Chinese medicine composition for treating chronic pulmonary heart disease and preparation method of traditional Chinese medicine composition |
CN105169061A (en) * | 2015-10-09 | 2015-12-23 | 刘焰琼 | Formula for treating excessive phlegm and yellow phlegm |
CN105194166A (en) * | 2015-11-08 | 2015-12-30 | 长沙佰顺生物科技有限公司 | Medicine composition for treating heart diseases |
-
1998
- 1998-10-29 CN CN98123782A patent/CN1123354C/en not_active Expired - Fee Related
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100490787C (en) * | 2003-12-26 | 2009-05-27 | 王保安 | Capsule for treating heart palpitation |
CN104524535A (en) * | 2015-01-15 | 2015-04-22 | 范丰双 | Traditional Chinese medicine composition for treating chronic pulmonary heart disease and preparation method of traditional Chinese medicine composition |
CN104524535B (en) * | 2015-01-15 | 2017-11-03 | 范丰双 | It is a kind of to treat Chinese medicine composition of chronic cor pulmonale and preparation method thereof |
CN105169061A (en) * | 2015-10-09 | 2015-12-23 | 刘焰琼 | Formula for treating excessive phlegm and yellow phlegm |
CN105194166A (en) * | 2015-11-08 | 2015-12-30 | 长沙佰顺生物科技有限公司 | Medicine composition for treating heart diseases |
Also Published As
Publication number | Publication date |
---|---|
CN1123354C (en) | 2003-10-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111773308A (en) | Traditional Chinese medicine composition of 'lung-ventilating and toxin-expelling decoction' for preventing and treating new coronary pneumonia and preparation method | |
CN104587298A (en) | Traditional Chinese medicinal composition for treating pulmonary abscess | |
CN1739611A (en) | Stasis relieving oral liquid for treating rhinitis and its prepn | |
CN103463417B (en) | Traditional Chinese medicine used for treating irritable bowel syndrome | |
CN1123354C (en) | Medicine for treating pulmonary hart diseases | |
CN101953924A (en) | Traditional Chinese medicine for treating chronic hepatitis | |
CN1097621A (en) | Anti-cancer powder | |
CN1101199C (en) | Chinese-medicinal capsule for treating hyperlipomia | |
CN1133458C (en) | Chinese herb medicine preparation for curing prolapse of lumbar intervertebral disk | |
CN1055220C (en) | Chinese drug for treatment of hemiplegia | |
CN102091165A (en) | Traditional Chinese medicine for treating chronic hepatitis | |
CN101953925A (en) | Traditional Chinese medicine for treating chronic hepatitis | |
CN101940723A (en) | Chinese medicinal preparation for treating pyelonephritis | |
CN101991685A (en) | Traditional Chinese medicine for treating chronic hepatitis | |
CN1259090C (en) | Oral liquid for treating common cold and coughing | |
CN102727765B (en) | Internally-used medicine for treating aplastic anemia by nourishing yin and yang | |
CN102048930A (en) | Formula of traditional Chinese medicine for treating chronic gastritis | |
CN1140284C (en) | Chinese-medicinal pill for treating rheumatoid arthritis | |
CN113274470B (en) | Traditional Chinese medicine composition for treating novel coronavirus pneumonia | |
CN102068533A (en) | Traditional Chinese medicine for treating chronic hepatitis | |
CN1515284A (en) | Rongshuan jiannaokang thrombolytic | |
CN1076622C (en) | Chinese medicine for curing nephritis | |
CN105434634A (en) | Traditional Chinese medicine composition for treating anemia | |
CN1056308C (en) | Medicine for adjusting cranial nerve function | |
CN1049134C (en) | Chinese prepared medicine for curing apoplexy |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C19 | Lapse of patent right due to non-payment of the annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |